PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.

about

Primary prevention of atherosclerosis by pretreatment of low-density lipoprotein receptor knockout mice with sesame oil and its aqueous components

P2860

Q58774514-A03FE9E9-0861-4E60-A94D-8E398F5854A4

P2860

PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.

Item

http://www.wikidata.org/entity/Q49459817

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

PCSK9 deficiency reduces ather ...... , and endothelial dysfunction.

@en

PCSK9 deficiency reduces ather ...... , and endothelial dysfunction.

@nl

type

Item

label

PCSK9 deficiency reduces ather ...... , and endothelial dysfunction.

@en

PCSK9 deficiency reduces ather ...... , and endothelial dysfunction.

@nl

prefLabel

PCSK9 deficiency reduces ather ...... , and endothelial dysfunction.

@en

PCSK9 deficiency reduces ather ...... , and endothelial dysfunction.

@nl

P1476

PCSK9 deficiency reduces ather ...... , and endothelial dysfunction.

@en

P2093

Ba-Bie Teng

http://www.w3.org/2001/XMLSchema#string

Hua Sun

http://www.w3.org/2001/XMLSchema#string

Jeffrey T Chang

http://www.w3.org/2001/XMLSchema#string

Ronald M Krauss

http://www.w3.org/2001/XMLSchema#string

P2860

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation

Self-association of human PCSK9 correlates with its LDLR-degrading activity

Proprotein convertase subtilisin/kexin type 9 interacts with apolipoprotein B and prevents its intracellular degradation, irrespective of the low-density lipoprotein receptor

Autophagy in vascular disease

Autophagy in the Pathogenesis of Disease

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

To be or not to be? How selective autophagy and cell death govern cell fate

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

p38 mitogen-activated protein kinase (MAPK) promotes cholesterol ester accumulation in macrophages through inhibition of macroautophagy.

P304

207-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M078360

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29180444

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

5794417

http://www.w3.org/2001/XMLSchema#string

PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.

about

P2860

P2860

PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932